Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity, and outcome to neoadjuvant chemotherapy
Open Access
- 11 November 2011
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 25 (3), 388-397
- https://doi.org/10.1038/modpathol.2011.172
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells Is Primarily Due To Isoform ALDH1A3 and Its Expression Is Predictive of MetastasisThe International Journal of Cell Cloning, 2010
- Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast CancerClinical Cancer Research, 2010
- Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancerBritish Journal of Cancer, 2009
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating featuresProceedings of the National Academy of Sciences of the United States of America, 2009
- Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following ChemotherapyPLOS ONE, 2008
- The CD44+/CD24-phenotype is enriched in basal-like breast tumorsBreast Cancer Research, 2008
- ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical OutcomeCell Stem Cell, 2007
- Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumorsGenome Biology, 2007
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences of the United States of America, 2001
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987